Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Biofactors (Oxford, England)|April 24, 2026
ISG15 Mediates Oxidative Stress Modulation in T2DM Patients by Directly Targeting PIK3R2Mei-Qi He, Jie Liu, Gao-Peng Guan, et al.
The FEBS Journal|March 6, 2025
TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseasesKun Huang, Qi Zhang, Hao Wan, et al.
Frontiers in Cell and Developmental Biology|January 3, 2022
Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related DiseasesQi Zhang, Xin-Xing Wan, Xi-Min Hu, et al.
Expert Opinion on Investigational Drugs|November 19, 2011
Identification of heptapeptides interacting with IFN-α-sensitive CML cellsJia Liu, Han-chun Chen, Zhou-zhou Rao, et al.
Frontiers in Endocrinology|April 4, 2022
Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell ReplacementXin-Xing Wan, Dan-Yi Zhang, Md Asaduzzaman Khan, et al.
Biomed Research International|October 1, 2015
Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML CellsFu-Lan Yang, Fang-Zhi Chen, Xin-Xing Wan, et al.
Experimental Dermatology|April 22, 2023
Pyroptosis-related gene signature elicits immune response in rosaceaXi-Min Hu, Sheng-Yuan Zheng, Rui Mao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 30, 2010
Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibilityYa-Ping Luo, Han-Chun Chen, Md Asaduzzaman Khan, et al.
Frontiers in Immunology|October 30, 2024
Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024Kun Huang, Ye He, Hao Wan, et al.
World Journal of Diabetes|May 1, 2023
Therapeutic role of growth factors in treating diabetic woundShen-Yuan Zheng, Xin-Xing Wan, Piniel Alphayo Kambey, et al.
Pageof 3